BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 16679488)

  • 1. Tamoxifen and raloxifene differ in their functional interactions with aspartate 351 of estrogen receptor alpha.
    Dayan G; Lupien M; Auger A; Anghel SI; Rocha W; Croisetière S; Katzenellenbogen JA; Mader S
    Mol Pharmacol; 2006 Aug; 70(2):579-88. PubMed ID: 16679488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The key to the antiestrogenic mechanism of raloxifene is amino acid 351 (aspartate) in the estrogen receptor.
    Levenson AS; Jordan VC
    Cancer Res; 1998 May; 58(9):1872-5. PubMed ID: 9581827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of tamoxifen and raloxifene on normal human endometrial cells in an organotypic in vitro model.
    Bläuer M; Heinonen PK; Rovio P; Ylikomi T
    Eur J Pharmacol; 2008 Sep; 592(1-3):13-8. PubMed ID: 18638473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Silencing and reactivation of the selective estrogen receptor modulator-estrogen receptor alpha complex.
    Liu H; Lee ES; Deb Los Reyes A; Zapf JW; Jordan VC
    Cancer Res; 2001 May; 61(9):3632-9. PubMed ID: 11325832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential effects of estradiol, raloxifene and tamoxifen on estrogen receptor expression in cultured human skin fibroblasts.
    Haczynski J; Tarkowski R; Jarzabek K; Wolczynski S; Magoffin DA; Czarnocki KJ; Ziegert M; Jakowicki J; Jakimiuk AJ
    Int J Mol Med; 2004 Jun; 13(6):903-8. PubMed ID: 15138633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-function relationships of the raloxifene-estrogen receptor-alpha complex for regulating transforming growth factor-alpha expression in breast cancer cells.
    Liu H; Park WC; Bentrem DJ; McKian KP; Reyes Ade L; Loweth JA; Schafer JM; Zapf JW; Jordan VC
    J Biol Chem; 2002 Mar; 277(11):9189-98. PubMed ID: 11751902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth response of colon cancer cell lines to selective estrogen receptor modulators.
    Picariello L; Fiorelli G; Martineti V; Tognarini I; Pampaloni B; Tonelli F; Brandi ML
    Anticancer Res; 2003; 23(3B):2419-24. PubMed ID: 12894523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of aspartate 351 in transactivation and active conformation of estrogen receptor alpha.
    Kim JH; Lee MH; Kim BJ; Kim JH; Han SJ; Kim HY; Stallcup MR
    J Mol Endocrinol; 2005 Dec; 35(3):449-64. PubMed ID: 16326832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. On-line formation, separation, and estrogen receptor affinity screening of cytochrome P450-derived metabolites of selective estrogen receptor modulators.
    van Liempd SM; Kool J; Niessen WM; van Elswijk DE; Irth H; Vermeulen NP
    Drug Metab Dispos; 2006 Sep; 34(9):1640-9. PubMed ID: 16790557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective oestrogen receptor (ER) modulators reduce microglia reactivity in vivo after peripheral inflammation: potential role of microglial ERs.
    Tapia-Gonzalez S; Carrero P; Pernia O; Garcia-Segura LM; Diz-Chaves Y
    J Endocrinol; 2008 Jul; 198(1):219-30. PubMed ID: 18460549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective estrogen receptor modulators with conformationally restricted side chains. Synthesis and structure-activity relationship of ERalpha-selective tetrahydroisoquinoline ligands.
    Renaud J; Bischoff SF; Buhl T; Floersheim P; Fournier B; Geiser M; Halleux C; Kallen J; Keller H; Ramage P
    J Med Chem; 2005 Jan; 48(2):364-79. PubMed ID: 15658851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of oestrogen agonists on human dermal fibroblasts in an in vitro wounding assay.
    Stevenson S; Sharpe DT; Thornton MJ
    Exp Dermatol; 2009 Nov; 18(11):988-90. PubMed ID: 19469894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiestrogens and selective estrogen receptor modulators as multifunctional medicines. 2. Clinical considerations and new agents.
    Jordan VC
    J Med Chem; 2003 Mar; 46(7):1081-111. PubMed ID: 12646017
    [No Abstract]   [Full Text] [Related]  

  • 14. Differential effects of raloxifene and tamoxifen on the expression of estrogen receptors and antigen Ki-67 in human endometrial adenocarcinoma cell line.
    Koda M; Jarzabek K; Haczynski J; Knapp P; Sulkowski S; Wolczynski S
    Oncol Rep; 2004 Sep; 12(3):517-21. PubMed ID: 15289830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of two novel selective estrogen receptor modulators, raloxifene, tamoxifen, and ethinyl estradiol on the uterus, vagina and breast in ovariectomized cynomolgus monkeys (Macaca fascicularis).
    Sikoski P; Register TC; Lees CJ; Lundeen S; Hutchison J; Brown KH; Cline JM
    Am J Obstet Gynecol; 2007 Jan; 196(1):75.e1-7. PubMed ID: 17240242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estrogen receptor modulators: identification and structure-activity relationships of potent ERalpha-selective tetrahydroisoquinoline ligands.
    Renaud J; Bischoff SF; Buhl T; Floersheim P; Fournier B; Halleux C; Kallen J; Keller H; Schlaeppi JM; Stark W
    J Med Chem; 2003 Jul; 46(14):2945-57. PubMed ID: 12825935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of selective estrogen receptor modulators in nude mice bearing human transitional cell carcinoma.
    Sonpavde G; Okuno N; Weiss H; Yu J; Shen SS; Younes M; Jian W; Lerner SP; Smith CL
    Urology; 2007 Jun; 69(6):1221-6. PubMed ID: 17572228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lead identification of a potent benzopyranone selective estrogen receptor modulator.
    McKie JA; Bhagwat SS; Brady H; Doubleday M; Gayo L; Hickman M; Jalluri RK; Khammungkhune S; Kois A; Mortensen D; Richard N; Sapienza J; Shevlin G; Stein B; Sutherland M
    Bioorg Med Chem Lett; 2004 Jul; 14(13):3407-10. PubMed ID: 15177442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estrogen receptor α L543A,L544A mutation changes antagonists to agonists, correlating with the ligand binding domain dimerization associated with DNA binding activity.
    Arao Y; Hamilton KJ; Coons LA; Korach KS
    J Biol Chem; 2013 Jul; 288(29):21105-21116. PubMed ID: 23733188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Benzothiophenes containing a piperazine side chain as selective ligands for the estrogen receptor alpha and their bioactivities in vivo.
    Yang C; Xu G; Li J; Wu X; Liu B; Yan X; Wang M; Xie Y
    Bioorg Med Chem Lett; 2005 Mar; 15(5):1505-7. PubMed ID: 15713417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.